Back

Global and national insights into the decline of hypertrophic cardiomyopathy as a cause of sudden death in the young

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Cardiomyopathies uncovered Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Dean Nelson

St Vincent's Hospital, Melbourne (Australia)

5 More presentations in this session

Presentation thumbnail
Fabry cardiomyopathy: myocardial fibrosis, inflammation and reduced mannose6phosphate receptors cause low accessibility to enzyme therapy.
Associate Professor A. Frustaci (Rome, IT)
Abstract Slides Video
Presentation thumbnail
Proteomic profiling of extracellular vesicles in takotsubo syndrome
Mr E. Zulfaj (Gothenburg, SE)
Abstract Slides Video
Presentation thumbnail
Changes in blood metabolomes as potential biomarkers for severity and prognosis in doxorubicin-induced heart failure: a study in HER2-positive and HER2-negative breast cancer patients
Associate Professor C. Thonusin (Chiang Mai, TH)
Abstract Slides Video
Presentation thumbnail
Clinical validated risk prediction model for development of heart failure after contemporary breast cancer treatment
Professor A. Barac (Fairfax, US)
Abstract Slides Video
Presentation thumbnail
Association of genetically predicted human metabolomic gene expression with incident heart failure
Mr H. Ahn (London, GB)
Abstract Slides Video

Access the full session

Session thumbnail
Cardiomyopathies uncovered
Video

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources